logo
Blog
  • eSource DDC
  • eCOA
  • ePRO
  • eConsent
  • BYOD
  • |
  • Back to clinicalink.com

Author: Doug Pierce

ePRO / eCOA

Mixed-Modality Deployment Compatible With Any Trial Design

Part I (of III)

Read More
Doug Pierce Doug Pierce December 2, 2020
ePRO / eCOA

A Unified Experience in eSource Patient Data Capture and Integration for Sites and Sponsors

Part II (of III)

Read More
Doug Pierce Doug Pierce December 2, 2020

Receive Industry Updates
SUBSCRIBE TO OUR BLOG

Filter By Category

  • BYOD (2)
  • CNS (2)
  • eCOA (14)
  • eCOA/ePRO (1)
  • eConsent (2)
  • ePRO (12)
  • eSource DDC (7)
  • Gastrointestinal (1)
  • Infectious Disease (2)
  • Lupus (3)
  • Oncology (1)
See all

Filter By Author

  • Doug Pierce (7)
  • Ed Seguine (3)
  • Jonathan Andrus (8)
  • Kim Romanello (3)
  • Rinah Yamamoto (1)
  • Tess Dugan (1)
See all

Popular Articles

eSource DDC

DDC vs. EDC: Frequently Asked Questions

eSource DDC

eSource: 6 Steps to Understanding

More From Clinical Ink

Screen Shot 2020-12-15 at 10.23.01 AM-1 Fact Sheet

Virtual Trials: Trust in Experience, Trust in Lunexis™

ClinicalInk_WhitePaper_GI_7-7-20_VF_Cover-1 White Paper

Improve GI Data and Patient Engagement With GI ePRO/eCOA

Clinical-Ink_Successful-BYOD_screenshot White Paper

Successful BYOD in Any Phase

More Articles

ePRO / eCOA

One Patient Data Capture Application That’s Everything to Everyone: The Evolution of Lunexis™ ePRO+

eSource DDC

DDC vs. EDC: Frequently Asked Questions

Lupus / eCOA

Lupus Studies Deserve a Better Approach

Lupus / eCOA

Happy Site, Happy Life: Illuminate the Path to a Brighter Future for Lupus Research by Easing Site Workflows

Lupus / eCOA

eLAS® — Changing the Landscape of Lupus Clinical Trials

All posts

About Clinical Ink

Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our Lunexis™ eSource clinical technology and configurable direct data capture, eCOA, patient engagement, telehealth, eConsent, and instrumented data collection modules provide a suite of solutions for capturing and integrating electronic data from sites, clinicians, caregivers, and patients at its source. Clinical Ink’s therapeutic-area-specific approach to study design and data capture — with specific expertise in neurocognitive testing — enables more precise scales for cognitive and human factors assessments, including performance, behavior, movement, and all real-world activity.